SERPINE1 and familial dilated cardiomyopathy: Huang et al. (2018) found that Fos proto-oncogene, AP-1 transcription factor subunit, tissue inhibitor of metalloprotease-1, and serpin family E member 1 may serve as therapeutic targets in DCM [25].